We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · May 08, 2015

Concomitant Carcinoma and Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma

The Journal of Urology


Additional Info

The Journal of Urology
The Effect of Concomitant Carcinoma in Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathological Outcomes but No Effect on Survival
J Urol 2015 May 01;193(5)1494-1499, WP Parker, PL Ho, JJ Melquist, K Scott, JM Holzbeierlein, E Lopez-Corona, AM Kamat, EK Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading